SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-285096
Filing Date
2017-09-14
Accepted
2017-09-14 16:10:06
Documents
8
Period of Report
2017-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d443622d8k.htm 8-K 26409
2 EX-4.1 d443622dex41.htm EX-4.1 63887
3 EX-5.1 d443622dex51.htm EX-5.1 8942
4 EX-10.1 d443622dex101.htm EX-10.1 218827
5 EX-23.1 d443622dex231.htm EX-23.1 1600
6 EX-99.1 d443622dex991.htm EX-99.1 4634
7 GRAPHIC g443622g11a13.jpg GRAPHIC 9293
8 GRAPHIC g443622g67q28.jpg GRAPHIC 4351
  Complete submission text file 0001193125-17-285096.txt   344754
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 171085781
SIC: 2835 In Vitro & In Vivo Diagnostic Substances